Zobrazeno 1 - 2
of 2
pro vyhledávání: '"T Palacek"'
Autor:
F Cappelli, P Kale, M Maurer, M Fontana, M Grogan, F Fernandes, T Palacek, M Taylor, R Hung, A González–duarte, S Puolsen, E Donal, F Perfetto, K Tsujita, W Yu, N Sarswat, M White, E Yureneva, P Jay, J Vest, J Gillmore
Publikováno v:
European Heart Journal Supplements. 25:D181-D182
Introduction Transthyretin–mediated (ATTR) amyloidosis is a progressive and fatal disease. Patients with hereditary or wild–type ATTR amyloidosis frequently develop cardiomyopathy (CM). Patisiran, an IV RNAi therapeutic that inhibits synthesis of
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::8f734daf5a40bba1d89471feb13814d5
https://doi.org/10.1093/eurheartjsupp/suad111.425
https://doi.org/10.1093/eurheartjsupp/suad111.425
Autor:
Barbey F; Department of Transplantation, Faculty of Medicine and Biology, University Hospital, Lausanne, Switzerland. frederic.barbey@chuv.ch, Qanadli SD, Juli C, Brakch N, Palacek T, Rizzo E, Jeanrenaud X, Eckhardt B, Linhart A
Publikováno v:
European heart journal [Eur Heart J] 2010 Feb; Vol. 31 (3), pp. 347-53. Date of Electronic Publication: 2009 Oct 21.